Corentin du Roy joined HarbourVest in 2003 and focuses on direct co-investments in buyout and growth equity transactions in Europe and around the world. He serves as a director of EA Pharma. He serves on the Firm’s Direct Investment Committee and led several of the Firm’s investments including Inelo (acquired by Eurowag), Deliveroo, Eaton Towers (acquired by American Tower), Klarna, Marle, GTS Central Europe (acquired by Deutsche Telekom), Omega Pharma (acquired by Perrigo), Minimax, Prosol (Grand Frais), Nycomed (acquired by Takeda), Kiala (acquired by UPS), and Loxam.
He joined the Firm from AXA Investment Managers, where he was an equity and high-yield debt research analyst focusing mainly on the telecom sector.
Fluent in French, Corentin received a BS (with distinction) in Business Administration from Paris IX Dauphine University in 1999 and received the Chartered Financial Analyst designation in 2002.